1. Home
  2. APGE vs HUBG Comparison

APGE vs HUBG Comparison

Compare APGE & HUBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • HUBG
  • Stock Information
  • Founded
  • APGE 2022
  • HUBG 1971
  • Country
  • APGE United States
  • HUBG United States
  • Employees
  • APGE N/A
  • HUBG N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • HUBG Oil Refining/Marketing
  • Sector
  • APGE Health Care
  • HUBG Consumer Discretionary
  • Exchange
  • APGE Nasdaq
  • HUBG Nasdaq
  • Market Cap
  • APGE 2.6B
  • HUBG 2.1B
  • IPO Year
  • APGE 2023
  • HUBG 1996
  • Fundamental
  • Price
  • APGE $40.82
  • HUBG $36.10
  • Analyst Decision
  • APGE Strong Buy
  • HUBG Buy
  • Analyst Count
  • APGE 4
  • HUBG 9
  • Target Price
  • APGE $97.50
  • HUBG $43.57
  • AVG Volume (30 Days)
  • APGE 1.3M
  • HUBG 510.6K
  • Earning Date
  • APGE 08-11-2025
  • HUBG 07-31-2025
  • Dividend Yield
  • APGE N/A
  • HUBG 1.39%
  • EPS Growth
  • APGE N/A
  • HUBG N/A
  • EPS
  • APGE N/A
  • HUBG 1.70
  • Revenue
  • APGE N/A
  • HUBG $3,862,113,000.00
  • Revenue This Year
  • APGE N/A
  • HUBG N/A
  • Revenue Next Year
  • APGE $743.14
  • HUBG $6.74
  • P/E Ratio
  • APGE N/A
  • HUBG $21.20
  • Revenue Growth
  • APGE N/A
  • HUBG N/A
  • 52 Week Low
  • APGE $26.20
  • HUBG $30.75
  • 52 Week High
  • APGE $63.50
  • HUBG $53.21
  • Technical
  • Relative Strength Index (RSI)
  • APGE 52.23
  • HUBG 58.08
  • Support Level
  • APGE $37.05
  • HUBG $33.63
  • Resistance Level
  • APGE $42.29
  • HUBG $34.79
  • Average True Range (ATR)
  • APGE 2.01
  • HUBG 1.01
  • MACD
  • APGE 0.18
  • HUBG 0.13
  • Stochastic Oscillator
  • APGE 77.66
  • HUBG 73.96

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About HUBG Hub Group Inc.

Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset-light truck brokerage operations along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub often makes tuck-in acquisitions that expand its brokerage, last-mile, and dedicated offerings.

Share on Social Networks: